financetom
Business
financetom
/
Business
/
--Boeing Starliner Thruster Issue Reportedly Delays Docking With International Space Station
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
--Boeing Starliner Thruster Issue Reportedly Delays Docking With International Space Station
Jun 6, 2024 10:15 AM

12:51 PM EDT, 06/06/2024 (MT Newswires) --

Price: 190.33, Change: +0.48, Percent Change: +0.25

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Tilray Brands' Tilray Medical Division Launches Redecan Cannabis Brand in Australia
Tilray Brands' Tilray Medical Division Launches Redecan Cannabis Brand in Australia
Sep 21, 2024
08:14 AM EDT, 09/18/2024 (MT Newswires) -- Tilray Brands' ( TLRY ) Tilray Medical division said Wednesday that its Redecan certified medical cannabis products are now available in Australia. Tilray Medical said the products it is selling in Australia include 15g Redecan PC THC28 Purple Churro and 15g Redecan SA THC28 Space Age Cake. ...
Vivos Therapeutics' Sleep Disorder Treatment Device Receives FDA Clearance
Vivos Therapeutics' Sleep Disorder Treatment Device Receives FDA Clearance
Sep 21, 2024
07:37 AM EDT, 09/18/2024 (MT Newswires) -- Vivos Therapeutics ( VVOS ) said Wednesday that it received the US Food and Drug Administration's 510(k) clearance for its oral medical device, which treats moderate to severe obstructive sleep apnea. The company said the noninvasive, safe, and effective device is part of its CARE line and intended for children diagnosed with obstructive...
Merck Secures FDA Approval for Keytruda Combination Therapy as Malignant Pleural Mesothelioma Treatment
Merck Secures FDA Approval for Keytruda Combination Therapy as Malignant Pleural Mesothelioma Treatment
Sep 21, 2024
07:20 AM EDT, 09/18/2024 (MT Newswires) -- Merck ( MRK ) said Wednesday that the US Food and Drug Administration has approved Keytruda's combination with emetrexed and platinum chemotherapy as first-line treatment for adult patients with unresectable advanced or metastatic malignant pleural mesothelioma. The company said the approval was based on data from a phase 2/3 trial, where the combination...
AstraZeneca Says US FDA Approves Fasenra for Rare Vasculitis Treatment
AstraZeneca Says US FDA Approves Fasenra for Rare Vasculitis Treatment
Sep 21, 2024
07:42 AM EDT, 09/18/2024 (MT Newswires) -- AstraZeneca ( AZN ) said Wednesday that its Fasenra (benralizumab) was approved by the US Food and Drug Administration for treating adult patients with eosinophilic granulomatosis with polyangiitis, a rare and potentially fatal immune-mediated vasculitis. The approval was based on results from a late-stage trial, where nearly 60% of patients treated with Fasenra...
Copyright 2023-2026 - www.financetom.com All Rights Reserved